SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19.
Journal: MedRxiv : The Preprint Server For Health Sciences
Published:
Abstract
SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a longer time since onset of infection in MIS-C patients.
Authors
Elizabeth Anderson, Caroline Diorio, Eileen Goodwin, Kevin Mcnerney, Madison Weirick, Sigrid Gouma, Marcus Bolton, Claudia Arevalo, Julie Chase, Philip Hicks, Tomaz Manzoni, Amy Baxter, Kurt Andrea, Chakkapong Burudpakdee, Jessica Lee, Laura Vella, Sarah Henrickson, Rebecca Harris, E Wherry, Paul Bates, Hamid Bassiri, Edward Behrens, David Teachey, Scott Hensley
Relevant Conditions